166 related articles for article (PubMed ID: 37708241)
1. Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathy.
Schipper MR; Vlegels N; van Harten TW; Rasing I; Koemans EA; Voigt S; Luca A; Kaushik K; van Etten ES; van Zwet EW; Terwindt GM; Biessels GJ; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2144-2155. PubMed ID: 37708241
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
[TBL] [Abstract][Full Text] [Related]
3. Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
Koemans EA; Rasing I; Voigt S; van Harten TW; van der Zwet RGJ; Kaushik K; Schipper MR; van der Weerd N; van Zwet EW; van Etten ES; van Osch MJP; Kuiperij B; Verbeek MM; Terwindt GM; Greenberg SM; van Walderveen MAA; Wermer MJH
Stroke; 2024 Apr; 55(4):954-962. PubMed ID: 38445479
[TBL] [Abstract][Full Text] [Related]
4. Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
van Harten TW; Heijmans A; van Rooden S; Wermer MJH; van Osch MJP; Kuijf HJ; van Veluw SJ; Greenberg SM; van Buchem MA; van der Grond J; van Walderveen MAA
J Alzheimers Dis; 2022; 90(1):381-388. PubMed ID: 36120778
[TBL] [Abstract][Full Text] [Related]
5. Mediators of cognitive impairment in cerebral amyloid angiopathy.
Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
van Dijk SE; van der Grond J; Lak J; van den Berg-Huysmans A; Labadie G; Terwindt GM; Wermer MJH; Gurol ME; van Buchem MA; Greenberg SM; van Rooden S
Stroke; 2022 Jun; 53(6):2006-2015. PubMed ID: 35360926
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.
van Opstal AM; van Rooden S; van Harten T; Ghariq E; Labadie G; Fotiadis P; Gurol ME; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; van der Grond J
Lancet Neurol; 2017 Feb; 16(2):115-122. PubMed ID: 27989553
[TBL] [Abstract][Full Text] [Related]
8. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
[TBL] [Abstract][Full Text] [Related]
9. Aging Effect, Reproducibility, and Test-Retest Reliability of a New Cerebral Amyloid Angiopathy MRI Severity Marker-Cerebrovascular Reactivity to Visual Stimulation.
van Dijk SE; Lak J; Drenth N; Hafkemeijer A; Rombouts SARB; van der Grond J; van Rooden S
J Magn Reson Imaging; 2023 Mar; 57(3):909-915. PubMed ID: 35876045
[TBL] [Abstract][Full Text] [Related]
10. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
[TBL] [Abstract][Full Text] [Related]
11. Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy.
Horn MJ; Gokcal E; Becker JA; Das AS; Schwab K; Zanon Zotin MC; Goldstein JN; Rosand J; Viswanathan A; Polimeni JR; Duering M; Greenberg SM; Gurol ME
Front Neurosci; 2023; 17():1141007. PubMed ID: 37077322
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy.
Switzer AR; McCreary C; Batool S; Stafford RB; Frayne R; Goodyear BG; Smith EE
Neuroimage Clin; 2016; 11():461-467. PubMed ID: 27104140
[TBL] [Abstract][Full Text] [Related]
13. Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.
Gokcal E; Horn MJ; Becker JA; Das AS; Schwab K; Biffi A; Rost N; Rosand J; Viswanathan A; Polimeni JR; Johnson KA; Greenberg SM; Gurol ME
J Cereb Blood Flow Metab; 2022 Jul; 42(7):1272-1281. PubMed ID: 35086372
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar hemorrhages in patients with Dutch-type hereditary cerebral amyloid angiopathy.
Voigt S; de Kruijff PC; Koemans EA; Rasing I; van Etten ES; Terwindt GM; van Osch M; van Buchem MA; van Walderveen M; Wermer M
Int J Stroke; 2022 Jul; 17(6):637-644. PubMed ID: 34427476
[TBL] [Abstract][Full Text] [Related]
15. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy.
Kaushik K; de Kort AM; van Dort R; van der Zwet RGJ; Siegerink B; Voigt S; van Zwet EW; van der Plas MC; Koemans EA; Rasing I; Kessels RPC; Middelkoop HAM; Schreuder FHBM; Klijn CJM; Verbeek MM; Terwindt GM; van Etten ES; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):74. PubMed ID: 38582898
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
Switzer AR; Cheema I; McCreary CR; Zwiers A; Charlton A; Alvarez-Veronesi A; Sekhon R; Zerna C; Stafford RB; Frayne R; Goodyear BG; Smith EE
Neurology; 2020 Sep; 95(10):e1333-e1340. PubMed ID: 32641520
[TBL] [Abstract][Full Text] [Related]
18. Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy.
Shirzadi Z; Yau WW; Schultz SA; Schultz AP; Scott MR; Goubran M; Mojiri-Forooshani P; Joseph-Mathurin N; Kantarci K; Preboske G; Wermer MJH; Jack C; Benzinger T; Taddei K; Sohrabi HR; Sperling RA; Johnson KA; Bateman RJ; Martins RN; Greenberg SM; Chhatwal JP;
Ann Neurol; 2022 Sep; 92(3):358-363. PubMed ID: 35670654
[TBL] [Abstract][Full Text] [Related]
19. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
20. Cerebral Amyloid Angiopathy With Vascular Iron Accumulation and Calcification.
Bulk M; Moursel LG; van der Graaf LM; van Veluw SJ; Greenberg SM; van Duinen SG; van Buchem MA; van Rooden S; van der Weerd L
Stroke; 2018 Sep; 49(9):2081-2087. PubMed ID: 30354978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
